| Autor: |
Jaeger U; Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, and Comprehensive Cancer Center, Vienna, Austria., Tam CS; Peter MacCallum Cancer Center, and Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC, Australia., Borchmann P; Clinic I for Internal Medicine, University Hospital of Cologne, Cologne, Germany., McGuirk JP; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, University of Kansas, Kansas City, KS., Johansen M; Department of Oncology, Oslo University Hospital, Oslo, Norway., Waller EK; Bone Marrow and Stem Cell Transplant Center, Winship Cancer Institute, Emory University, Atlanta, GA., Jaglowski S; James Cancer Hospital and Solove Research Institute, Ohio State University Comprehensive Cancer Center, Ohio State University, Columbus, OH., Andreadis C; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA., Foley SR; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada., Westin JR; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX., Fleury I; Maisonneuve-Rosement Hospital, University of Montreal, Montreal, QC, Canada., Ho PJ; Institute of Haematology, Royal Prince Alfred Hospital and University of Sydney, Camperdown, NSW, Australia., Mielke S; Department of Medicine II, University of Würzburg Medical Center, University of Würzburg, Würzburg, Germany.; Department of Laboratory Medicine and Department of Medicine Huddinge, Karolinska Institute and University Hospital, Stockholm, Sweden., Teshima T; Department of Hematology, Hokkaido University Hospital, Sapporo, Japan., Salles G; Memorial Sloan Kettering Cancer Center, New York, NY., Schuster SJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., He F; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN., Maziarz RT; Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health and Science University, Portland, OR., Mayer S; Division of Hematology-Oncology, Bone Marrow and Stem Cell Transplantation Service, Weill Cornell Medicine, Cornell University, New York, NY., Makita S; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan., Kersten MJ; Department of Hematology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Ghosh M; Blood and Marrow Transplantation Program, University of Michigan Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI., Wagner-Johnston N; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, MD., Kato K; Department of Hematology, Oncology, and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan., Corradini P; Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milan, Milan, Italy., Goto H; Department of Hematology, Hokkaido University Hospital, Sapporo, Japan., Colicino S; Novartis Pharmaceuticals, Basel, Switzerland., Agarwal A; Novartis Pharmaceuticals, East Hanover, NJ; and., Lobetti-Bodoni C; Novartis Pharmaceuticals, Basel, Switzerland., Bishop MR; Hematopoietic Cellular Therapy Program, Section of Hematology/Oncology, University of Chicago, Chicago, IL. |
